Capitalizing on New Needs and New Opportunities
Regular price
€81.99
14 days return policy
Shipping & Delivery
A01=Board on Science
A01=National Research Council
A01=Policy and Global Affairs
and Economic Policy
Author_Board on Science
Author_National Research Council
Author_Policy and Global Affairs
Category=K
eq_bestseller
eq_business-finance-law
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
Technology
Product details
- ISBN 9780309082570
- Dimensions: 152 x 229mm
- Publication Date: 11 Jan 2001
- Publisher: National Academies Press
- Publication City/Country: US
- Product Form: Paperback
Secure
checkout
Fast Shipping
Easy returns
This report addresses a topic of recognized policy concern. To capture the benefits of substantial U.S. investments in biomedical R&D, parallel investments in a wide range of seemingly unrelated disciplines are also required. This report summarizes a major conference that reviewed our nationa (TM)s R&D support for biotechnology and information technologies. The volume includes newly commissioned research and makes recommendations and findings concerning the important relationship between information technologies and biotechnology. It emphasizes the fall off in R&D investments needed to sustain the growth of the U.S. economy and to capitalize on the growing investment in biomedicine. It also encourages greater support for inter-disciplinary training to support new areas such as bioinformatics and urges more emphasis on and support for multi-disciplinary research centers.
Charles W. Wessner, Editor, Board on Science, Technology, and Economic Policy, National Research Council
